Here are five points:
1. The increasing popularity of minimally invasive spine surgery and growing international access to healthcare have allowed NuVasive to grow globally.
2. NuVasive found substantial growth in the Asia-Pacific and European markets. Japan, Australia and Italy especially contributed.
3. The company expects its international business to grow more than 20 percent in 2015.
4. Because the spine fusion market is expected to be $9 billion globally in 2015, NuVasive expects its line of surgical alternatives, offering less tissue disruption, will be in demand.
5. Pricing continues to present an obstacle for NuVasive.
More articles on devices:
Zimmer Biomet receives BBB+ credit rating — 4 facts
5 notes on Xenco Medical’s plastic spine instrument outperforming aluminum metal
Materialise, Lima partner on total knee replacements: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
